Method for the formation of ibuprofen crystals

Details for Australian Patent Application No. 2002342862 (hide)

Owner BASF AKTIENGESELLSCHAFT

Inventors Muller, Bernd W; Franke, Dirk; Rasenack, Norbert; Friese, Katrin; Einig, Heinz

Agent Watermark

Pub. Number AU-A-2002342862

PCT Number PCT/EP02/11999

PCT Pub. Number WO2003/039513

Priority 101 53 934.7 06.11.01 DE

Filing date 25 October 2002

Wipo publication date 19 May 2003

International Classifications

A61K 009/14 Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 031/192

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 101 53 934.7 06.11.01 DE

24 July 2003 Application Open to Public Inspection

  Published as AU-A-2002342862

6 April 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002342863-FUNCTIONS FOR D52 AND RA006 NUCLEIC ACIDS AND POLYPEPTIDES

2002342861-USE OF A DOUBLE-STRANDED RIBONUCLEIC ACID FOR SPECIFICALLY INHIBITING THE EXPRESSION OF A GIVEN TARGET GENE